ILKN421H Plus Pembrolizumab in Advanced Non-Small Cell Lung Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
ILKN421H Plus Pembrolizumab in Advanced Non-Small Cell Lung Cancer	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Recruiting	Phase 2	2026-07-10		NCT07452224

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
iLeukon Therapeutics, Inc.	1

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Start Ccbd, Llc	Fort Worth	United States	2
Valkyrie Clinical Trials, Inc	Los Angeles	United States	1

Clinical trials